MISSION! REMOTE Telemonitoring of Implantable Cardioverter Defibrillators: A randomized controlled trial
- Conditions
- Cardiac Arrhythmia10007521
- Registration Number
- NL-OMON32998
- Lead Sponsor
- eids Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 300
Inclusion Criteria
Indication for ICD or CRT-D
18 years of older
Capability to use either telemonitoring system throughout 12 months (Biotronik's Home Monitoring or Medtronic's CareLink)
Exclusion Criteria
Congenital heart disease
Instable Medical condition
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary purpose of this study is to evaluate whether telemonitoring can<br /><br>decrease the follow-up burden for ICD/CRT-D patients and clinic. Therefore, the<br /><br>number of interrogations will be assessed. Secondly the feasibility of<br /><br>telemonitoring will be tested by assessing the number of data-transmissions,<br /><br>patient compliance, ease of use and satisfaction. </p><br>
- Secondary Outcome Measures
Name Time Method <p>The first secondary objective will be to assess the value of asymptomatic<br /><br>events and alerts, as detected by telemonitoring. Early detection and<br /><br>resolution of silent events hold obvious promise in the advancement of patient<br /><br>care.<br /><br>In the second secondary objective, the potential cost benefit of telemonitoring<br /><br>will be assessed.<br /><br>Thirdly, the additional information acquired by telemonitoring will be<br /><br>assessed. The ICDs/CRT-Ds used in this study are equipped with several<br /><br>monitoring features, which are innovative but not (yet) implemented in current<br /><br>guidelines </p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the key biomarkers for predicting response to remote ICD monitoring in cardiac arrhythmia patients?
How does remote telemonitoring in NL-OMON32998 compare to standard in-person ICD follow-up for arrhythmia management?
What adverse events are associated with non-invasive ICD telemonitoring systems in cardiac arrhythmia trials?
What molecular mechanisms underlie arrhythmia detection accuracy in remote ICD monitoring protocols?
How does the MISSION! REMOTE trial influence the adoption of telemonitoring in post-ICD implantation care pathways?